Director/PDMR Shareholding

RNS Number : 8066E
Belluscura PLC
31 October 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED.  ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Belluscura PLC

("Belluscura" or the "Company" or "Group")

Exercise of Share Options and Total Voting Rights

 

Director / PDMR Shareholding and Share Options

 

LONDON, U.K. AND PLANO, TX, U.S.   (31 October 2022).  Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, confirms that following his e xercise of 690,395 share options in August and transfer of 364,833 shares to his ex-wife to facilitate settlement of divorce proceedings, Robert Rauker (CEO) and Belluscura, on the behalf of Gina Rauker, sold the remaining 235,331 shares to cover the related exercise cost and her associated taxes.

 

Mr Rauker's holding is 955,684 shares and his total interest in the Company is 0.78% of the Company's issued share capital.

 

 

 

Belluscura plc

www.belluscura.com

Robert Rauker, Chief Executive Officer

via MHP Communications

Anthony Dyer, Chief Financial Officer


 


SPARK Advisory Partners Ltd (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin


 


Dowgate Capital Ltd (Broker & Bookrunner)

Tel: +44 (0)20 3903 7715

James Serjeant / Nicholas Chambers


 


MHP Communications (Media & Investor Relations)

Tel: +44 (0)20 3128 8100

Katie Hunt / Pete Lambie / Matthew Taylor 

or belluscura@mhpc.com




 



 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 

 1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robert Rauker

2

Reason for notification

a)

Position / status

Chief Executive Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Belluscura plc

b)

LEI

213800BRJQZE56XBPW94

4

Details of the transaction(s): Section to be repeated for (i) each type of instrument; (ii) each type of transaction; 
(iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of £0.01 each in Belluscura plc

ISIN : GB00BD3B8Z11

b)

Nature of the transaction

(i)  Sale of share to cover exercise and associated taxes;

c)

Price(s) and volumes(s)

 (i)

Price(s)

Volumes(s)

(i)  45.0 pence

 

235,331

 

d)

Aggregated information

n/a

e)

Date of the transaction

28 October 2022

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMBBRTMTJJBFT

Companies

Belluscura (BELL)
UK 100

Latest directors dealings